The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Primary age-related tauopathy (PART): a common pathology associated with human aging
Open accessAbstract
We recommend a new term, "primary age-related tauopathy" (PART), to describe a pathology that is commonly observed in the brains of aged individuals. Many autopsy studies have reported brains with neurofibrillary tangles (NFTs) that are indistinguishable from those of Alzheimer's disease (AD), in the absence of amyloid (Aβ) plaques. For these "NFT+/Aβ-" brains, for which formal criteria for AD neuropathologic changes are not met, the NFTs are mostly restricted to structures in the medial temporal lobe, basal forebrain, brainstem, and olfactory areas (bulb and cortex). Symptoms in persons with PART usually range from normal to amnestic cognitive changes, with only a minority exhibiting profound impairment. Because cognitive impairment is often mild, existing clinicopathologic designations, such as "tangle-only dementia" and "tangle-predominant senile dementia", are imprecise and not appropriate for most subjects. PART is almost universally detectable at autopsy among elderly individuals, yet this pathological process cannot be specifically identified pre-mortem at the present time. Improved biomarkers and tau imaging may enable diagnosis of PART in clinical settings in the future. Indeed, recent studies have identified a common biomarker profile consisting of temporal lobe atrophy and tauopathy without evidence of Aβ accumulation. For both researchers and clinicians, a revised nomenclature will raise awareness of this extremely common pathologic change while providing a conceptual foundation for future studies. Prior reports that have elucidated features of the pathologic entity we refer to as PART are discussed, and working neuropathological diagnostic criteria are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Perivascular, subpial, and periventricular p-tau immunoreactive NFTs and astrocytic tangles in the neocortex have been reported to be characteristic of both primary age-related tauopathy (PART) [35] and age-related tau astrogliopathy (ARTAG) [36].”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Primary age-related tauopathy (PART) and aging-related tau astrogliopathy (ARTAG) are independent tau pathologies commonly observed in patients over 80 years of age, and PART may account for a proportion of the misdiagnosed clinical AD cases in the elderly [130, 141, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lesions are found in the hippocampus and adjacent regions similar to those observed in Braak I-IV, but PART is distinct from AD in that it lacks amyloid plaques, and it has distinct morbidity and age range [130, 142].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [142]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PART refers to neuronal tau pathology and ARTAG is characterized by astrocytic tau pathology, although they are not mutually exclusive, and appear to be more a manifestation of age than a subtype of neurodegenerative disease.”
From The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features (2017) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many studies, from the histopathology of Braak and Braak4 to longitudinal studies of Tau positron emission tomography imaging27,28, demonstrate that MTG is a transition zone between aging-related or preclinical AD-related medial temporal lobe pTau and more advanced stages of AD, where neocortical pTau extends across the brain and is strongly correlated with dementia4,29–31.”
From Integrated multimodal cell atlas of Alzheimer’s disease (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It should be noted that tau aggregation in the brain is associated with older age and is generally uncommon in healthy young adults (Braak et al., 2011; Crary et al., 2014).”
From Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms (2022) · cites this paper as Crary et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE and PART are common neuropathologies, indicating the importance of addressing potential relationships between AD-Mimics, and LATE and PART pathology in future research (20,22).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“AD-Mimics and definite PART are both defined as having no neuritic plaques, and like the AD-Mimics in this study, PART participants are generally older and experience less severe cognitive dysfunction (22,23).”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The compact NFTs observed are morphologically most like those seen in primary age-related tauopathy (PART) [4], Alzheimer’s disease (AD) [22], and chronic traumatic encephalopathy (CTE) [13, 14], but the topographical distribution and immunostaining characteristics differ from these more common tauopathies in several respects.”
From Tuberous sclerosis complex is associated with a novel human tauopathy (2023) · cites this paper as [4]
In the citing paper
“APOE4 significantly aggravated tau-mediated neurodegeneration in a tauopathy mouse model and induced tau aggregates in brain, while genetic ablation of APOE attenuated tau-induced neurodegeneration [469, 470].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [470]
In the citing paper
“In AD and PART, the tau aggregates are a mixture of three-repeat and four-repeat tau isoforms, whereas four-repeat sequences dominate in PSP and CBD and three-repeat sequences predominate in Pick disease14,18,19,21.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [14]
In the citing paper
“More recently, Crary et al. coined the term “primary age-related tauopathy” (PART) after observing that the postmortem brains of many elderly individuals harbor NFTs indistinguishable from those of AD but in the absence of Aβ plaques or cognitive decline [44].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [44]
In the citing paper
“The panel did not ultimately accept all of the a priori criteria for CTE; they did not include pathology known to be associated with aging (i.e.primary age-related tauopathy [PART] [16] and aging-related tau astrogliopathy [ARTAG] [17]).”
From Mild Chronic Traumatic Encephalopathy Neuropathology in People With No Known Participation in Contact Sports or History of Repetitive Neurotrauma (2019) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationBraak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Self-citationMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 3×
“the current guidelines for AD [64, 102], mild Aβ plaques”
BackgroundInfluentialSelf-citationConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,002
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia
Eisenmenger, L. B., Huo, E. J., Hoffman, J. M., Minoshima, S., Matesan, M. C., Lewis, D. H., Lopresti, B. J., Mathis, C. A., Okonkwo, D. O., & Mountz, J. M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.09.003 · Cited by 21
Hereditary primary lateral sclerosis and progressive nonfluent aphasia
Gazulla, J., Ferrer, I., Álvarez, S. I., Álvarez, S., Sánchez-Alcudia, R., Cardiel, M. B., Seral, M., Benavente, I., Sierra‐Martínez, E., & Berciano, J. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09235-x · Cited by 21
Laczó, M., Lerch, O., Martinkovič, L., Kalinová, J., Marková, H., Vyhnálek, M., Hort, J., & Laczó, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.774600 · Cited by 21
Impact of APOE genotype on prion-type propagation of tauopathy
Williams, T., Ruiz, A. J., Ruiz, A. M., Vo, Q., Tsering, W., Xu, G. M., McFarland, K. N., Giasson, B. I., Sullivan, P. M., Borchelt, D., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01359-y · Cited by 21
Farrell, K. W., Iida, M. A., Cherry, J. D., Casella, A., Stein, T. D., Bieniek, K. F., Walker, J. M., Richardson, T. E., White, C. L., Alvarez, V. E., et al. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac066 · Cited by 21
Self-citationFathy, Y. Y., Jonkman, L. E., Bol, J. G. J. M., Timmermans, E., Jonker, A. J., Rozemüller, A. J. M., & van de Berg, W. D. J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00325-x · Cited by 21
Transgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 21
Son, G., Neylan, T. C., & Grinberg, L. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00695-4 · Cited by 21
Self-citationWang, X., Zhu, K., Wu, W., Zhou, D., Lu, H., Du, J., Cai, L., Yan, X., Li, W., Qian, X., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14369 · Cited by 21
Thal, D. R., Zuchner, S. L., Gierer, S., Schulte, C., Schöls, L. J., Schüle, R., & Synofzik, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025050 · Cited by 21
Self-citationNeurodegenerative Diseases and Ageing
Walker, L., McAleese, K. E., Erskine, D., & Attems, J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_4 · Cited by 21
Self-citationMixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly
Alafuzoff, I. I., & Libard, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200925 · Cited by 21
Self-citationRaj, A. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0905 · Cited by 21
Gliebus, G. P. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000619 · Cited by 21
Morderer, D., Wren, M. C., Liu, F., Kouri, N., Maistrenko, A., Khalil, B., Pobitzer, N., Salemi, M., Phinney, B. S., Bu, G., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00817-0 · Cited by 21
Self-citationRaj, A., Torok, J., & Ranasinghe, K. G. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102750 · Cited by 20
Higuchi, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_18 · Cited by 20
Pelgrim, T. A. D., Beran, M., Twait, E. L., Geerlings, M. I., & Vonk, J. M. J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101449 · Cited by 21
Does essential tremor increase risk of cognitive impairment and dementia? Yes
Cosentino, S., & Shih, L. C. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.02.011 · Cited by 20
Xu, Y., Zheng, F., Zhong, Q., & Zhu, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230002 · Cited by 20
Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic
Bucci, M., Blūma, M., Savitcheva, I., Ashton, N. J., Chiotis, K., Matton, A., Kivipelto, M., Molfetta, G. D., Blennow, K., Zetterberg, H., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02558-4 · Cited by 20
Dissociating effects of aging and genetic risk of sporadic Alzheimer’s disease on path integration
Colmant, L., Bierbrauer, A., Bellaali, Y., Kunz, L., Dongen, J. V., Sleegers, K., Axmacher, N., Lefèvre, P., & Hanseeuw, B. J. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.07.025 · Cited by 20
Braak, H., Mayer, B., Feldengut, S., Schön, M., & Tredici, K. D. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02862-x · Cited by 20
Knopman, D. S., Jack, C. R., Lundt, E. S., Wiste, H. J., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2323 · Cited by 20
Self-citationPasquini, L., Scherr, M., Tahmasian, M., Myers, N. E., Ortner, M., Kurz, A., Förstl, H., Zimmer, C., Grimmer, T., Akhrif, A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150823 · Cited by 20
Plowey, E. D., & Ziskin, J. L. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0388-2 · Cited by 20
Tauopathies: Mechanisms and Therapeutic Strategies
Tan, C., Zhang, X.-Y., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170187 · Cited by 21
Decreased Muscle Strength and Quality in Diabetes-Related Dementia
Tsugawa, A., Ogawa, Y., Takenoshita, N., Kaneko, Y., Hatanaka, H., Jaime, E., Fukasawa, R., & Hanyu, H. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000485177 · Cited by 20
Disease-modifying therapies for tauopathies: agents in the pipeline
Panza, F., Imbimbo, B. P., Lozupone, M., Greco, A., Seripa, D., Logroscino, G., Daniele, A., & Colosimo, C. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1606715 · Cited by 20
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults
Halaas, N. B., Henjum, K., Blennow, K., Dakhil, S., Idland, A., Nilsson, L. N. G., Sederevičius, D., Dídac Vidal-piñeiro, A., Walhovd, K. B., Wyller, T. B., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz240 · Cited by 20
Key Physicochemical and Biological Factors of the Phase Behavior of Tau
Nam, G., Lin, Y., Lim, M. H., & Lee, Y. (2020) · Chem · doi:10.1016/j.chempr.2020.09.012 · Cited by 20
Goda, A., Murata, S., Nakano, H., Nonaka, K., Iwase, H., Shiraiwa, K., Abiko, T., Anami, K., & Horie, J. (2020) · Healthcare · doi:10.3390/healthcare8040567 · Cited by 20
Genetic Insights into Alzheimer's Disease
Latimer, C. S., Lucot, K. L., Keene, C. D., Cholerton, B., & Montine, T. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032551 · Cited by 20
Self-citationProtracted course progressive supranuclear palsy
Couto, B., Martínez-Valbuena, I., Lee, S., Alfradique‐Dunham, I., Perrin, R. J., Perlmutter, J. S., Cruchaga, C., Kim, A., Visanji, N. P., Sato, C., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15346 · Cited by 20
Lee, W. J., Cho, H., Baek, M. S., Kim, H., Lee, J., Ryu, Y. H., Lyoo, C. H., & Seong, J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01061-0 · Cited by 20
Llorens, F., Thüne, K., Andrés‐Benito, P., Tahir, W., Ansoleaga, B., Hernández‐Ortega, K., Martı́, E., Zerr, I., & Ferrer, I. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0971-4 · Cited by 20
Doering, S., McCullough, A. A., Gordon, B. A., Chen, C. D., McKay, N. S., Hobbs, D. A., Keefe, S., Flores, S. E., Scott, J., Smith, H. D., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105080 · Cited by 19
Blūma, M., Chiotis, K., Bucci, M., Savitcheva, I., Matton, A., Kivipelto, M., Jeromin, A., Santis, G. D., Molfetta, G. D., Ashton, N. J., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105504 · Cited by 19
Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism
Lee, Y., Jeon, S., Park, M.-C., Kang, S. W., Yoon, S. H., Baik, K., Lee, P. H., Sohn, Y. H., Ye, B. S., & Initiative, T. A. D. N. (2022) · Annals of Neurology · doi:10.1002/ana.26355 · Cited by 19
Assessment of Alzheimer-related pathologies of dementia using machine learning feature selection
Rajab, M. A., Jammeh, E., Taketa, T., Brayne, C., Matthews, F. E., Su, L., Ince, P. G., Wharton, S. B., Wang, D. Y. Q., & on behalf of the Cognitive Function and Ageing Neuropathology Study Group (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01195-9 · Cited by 19
Lozupone, M., Dibello, V., Sardone, R., Castellana, F., Zupo, R., Lampignano, L., Bortone, I., Stallone, R., Altamura, M., Bellomo, A., et al. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2200245 · Cited by 21
Role of brain infarcts in behavioral variant frontotemporal dementia
Torralva, T., Sposato, L. A., Riccio, P. M., Gleichgerrcht, E. L., Roca, M., Toledo, J. B., Trojanowski, J. Q., Kukull, W. A., Manes, F., & Hachinski, V. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.026 · Cited by 19
Self-citationAre AD-Typical Regions the Convergence Point of Multiple Pathologies?
Villeneuve, S., Wirth, M., & Joie, R. L. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00042 · Cited by 19
Familial early-onset dementia with complex neuropathologic phenotype and genomic background
Alexander, J., Kalev, O., Mehrabian, S., Traykov, L. D., Raycheva, M., Kanakis, D. N., Petros Drineas, B., Lutz, M. I., Ströbel, T., Penz, T., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.03.012 · Cited by 19
Moszczynski, A. J., Hintermayer, M. A., & Strong, M. J. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00259 · Cited by 19
Shigemoto, Y., Sone, D., Maikusa, N., Okamura, N., Furumoto, S., Kudo, Y., Ogawa, M., Takano, H., Yokoi, Y., Sakata, M., et al. (2018) · Brain and Behavior · doi:10.1002/brb3.1145 · Cited by 19
Blood-based protein mediators of senility with replications across biofluids and cohorts
Royall, D. R., Palmer, R. F., & Initiative, T. A. D. N. (2019) · Brain Communications · doi:10.1093/braincomms/fcz036 · Cited by 19
Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
Chen, C. D., Holden, T. R., Gordon, B. A., Franklin, E. E., Li, Y., Coble, D. W., Luo, H., Bateman, R. J., for the Dominantly Inherited Alzheimer Network (DIAN) and for the Dominantly Inherited Alzheimer Network Trials Unit (DIAN‐TU), Ances, B. M., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51237 · Cited by 19
Self-citationRobinson, A., Roncaroli, F., Davidson, Y. S., Minshull, J., Heal, C., Montaldi, D., Payton, A., Horan, M. A., Pendleton, N., & Mann, D. M. A. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5470 · Cited by 19
Quintas-Neves, M., Teylan, M., Morais‐Ribeiro, R., Almeida, F., Mock, C., Kukull, W. A., Crary, J. F., & Oliveira, T. G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.04.013 · Cited by 19
Self-citationMouzon, B., Saltiel, N. A., Ferguson, S., Ojo, J. O., Lungmus, C., Lynch, C., Algamal, M., Morin, A., Carper, B. A., Bieler, G. S., et al. (2018) · Brain Injury · doi:10.1080/02699052.2018.1486457 · Cited by 19
Schaeverbeke, J. M., Celen, S., Cornelis, J., Ronisz, A., Serdons, K., Laere, K. V., Thal, D. R., Tousseyn, T., Bormans, G. M., & Vandenberghe, R. R. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04631-x · Cited by 19
Self-citationSchwab, N., & Hazrati, L.-N. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180373 · Cited by 18
Systematic assessment of plasma biomarkers in spinocerebellar ataxia
Shen, X., Wu, K., Huang, Y., Guo, Y., Huang, S., Zhang, Y.-R., Chen, S., Wang, H.-F., Zhang, W. Y., Cheng, W., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106112 · Cited by 18
Passive tau-based immunotherapy for tauopathies
Panza, F., Solfrizzi, V., Daniele, A., & Lozupone, M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00029-6 · Cited by 18
Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers
Gomar, J. J., & Koppel, J. L. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.1389 · Cited by 18
Aliaga, A., Therriault, J., Quispialaya, K. M., Aliaga, A., Hopewell, R., Rahmouni, N., Macedo, A. C., Kunach, P., Soucy, J., Massarweh, G., et al. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.267539 · Cited by 18
Vickers, J. C., Kirkcaldie, M., Phipps, A. J., & King, A. E. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.07.012 · Cited by 18
Tauopathy with hippocampal 4‐repeat tau immunoreactive spherical inclusions: a report of three cases
Kovács, G. G., Kwong, L. K., Grossman, M., Irwin, D. J., Lee, E. B., Robinson, J. L., Suh, E. R., Deerlin, V. M. V., Lee, V. M., & Trojanowski, J. Q. (2016) · Brain Pathology · doi:10.1111/bpa.12482 · Cited by 18
Self-citationAdams, S. L., Benayoun, L., Tilton, K., Chavez, O. R., Himali, J. J., Blusztajn, J. K., Seshadri, S. S., & Delalle, I. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170459 · Cited by 18
Xing, S., Wang, J., Wu, R., Hefti, M. M., Crary, J. F., & Lu, Y. (2021) · RNA Biology · doi:10.1080/15476286.2021.2015175 · Cited by 18
Self-citationWalker, J. M., Gonzales, M. M., Goette, W. F., Farrell, K. W., White, C. L., Crary, J. F., & Richardson, T. E. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230022 · Cited by 18
Self-citationWęgiel, J., Flory, M. J., Kuchna, I., Nowicki, K., Ma, S. Y., Wegiel, J., Badmajew, E., Silverman, W. P., de Leon, M. J., Reisberg, ., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx027 · Cited by 18
Takemaru, M., Kimura, N., Abe, Y., Goto, M., & Matsubara, E. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.06.018 · Cited by 18
Andrés‐Benito, P., Delgado‐Morales, R., & Ferrer, I. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00131 · Cited by 18
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I. I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz226 · Cited by 18
Self-citationCerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions
Maillard, P., Fletcher, E. M., Carmichael, O. T., Schwarz, C. G., Seiler, S., DeCarli, C. S., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14358 · Cited by 17
Emsell, L., Laroy, M., Cauwenberge, M. G. A. V., Casteele, T. V., Vansteelandt, K., Laere, K. V., Sunaert, S. G., den Stock, J. V., Bouckaert, F., & Vandenbulcke, M. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03063-y · Cited by 17
Wakasugi, N., & Hanakawa, T. (2021) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2021.777706 · Cited by 17
Gonzalez, J., Wilson, A. M., Byrd, D., Cortes, E. P., Crary, J. F., & Morgello, S. (2023) · AIDS · doi:10.1097/qad.0000000000003556 · Cited by 17
Self-citationInteraction of Proteins Involved in Neuronal Proteinopathies
Kulichikhin, K. Y., Malikova, O. A., Zobnina, A. E., Zalutskaya, N. M., & Rubel, A. A. (2023) · Life · doi:10.3390/life13101954 · Cited by 17
Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
Fujishima, M., Kawasaki, Y., Mitsuhashi, T., Matsuda, H., & Initiative, A. D. N. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01450-7 · Cited by 17
Stein-O’Brien, G., Palaganas, R. G., Meyer, E. M., Redding‐Ochoa, J., Pletniková, O., Guo, H., Bell, W. R., Troncoso, J. C., Huganir, R. L., & Morris, M. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115422 · Cited by 18
Self-citationPrimary Age-Related Tauopathy in Human Subcortical Nuclei
Zhu, K., Wang, X., Sun, B., Wu, J., Lü, H., Zhang, X., Liang, H., Zhang, D., & Liu, C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00529 · Cited by 17
The relation between tau pathology and granulovacuolar degeneration of neurons
Puladi, B., Dinekov, M., Arzberger, T., Taubert, M., & Köhler, C. N. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105138 · Cited by 17
Li, Z., Li, K., Luo, X., Zeng, Q., Zhao, S., Zhang, B., Zhang, M., Chen, Y., & Initiative, A. D. N. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.550664 · Cited by 17
Neuropathologic Findings in Chronic Kidney Disease (CKD)
Vinters, H. V., Magaki, S., & Williams, C. K. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.105657 · Cited by 17
Lagarde, J., Olivieri, P., Tonietto, M., Gervais, P., Comtat, C., Caillé, F., Bottlaender, M., & Sarazin, M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01628-9 · Cited by 17
Histopathologic brain age estimation via multiple instance learning
Marx, G. A., Kauffman, J., McKenzie, A. T., Koenigsberg, D., McMillan, C. T., Morgello, S., Karlovich, E., Insausti, R., Richardson, T. E., Walker, J. M., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02636-3 · Cited by 19
Self-citationManassero, G., Guglielmotto, M., Monteleone, D., Vasciaveo, V., Butenko, O., Tamagno, E., Arancio, O., & Tabaton, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170298 · Cited by 17
Molecular signatures of premature aging in Major Depression and Substance Use Disorders
Onisiforou, A., Zanos, P., & Georgiou, P. (2024) · Scientific Data · doi:10.1038/s41597-024-03538-z · Cited by 17
Retromer dysfunction at the nexus of tauopathies
Carosi, J. M., Denton, D., Kumar, S., & Sargeant, T. J. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00727-2 · Cited by 16
Serum protein mediators of dementia and aging proper
Royall, D. R., Al-Rubaye, S., Bishnoi, R. J., & Palmer, R. F. (2016) · Aging · doi:10.18632/aging.101091 · Cited by 16
Sexton, C. E., Bitan, G., Bowles, K. R., Bryś, M., Buée, L., Maina, M. B., Clelland, C. D., Cohen, A. D., Crary, J. F., Dage, J. L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13533 · Cited by 16
Self-citationTaghdiri, F., Khodadadi, M., Sadia, N., Mushtaque, A., Scott, O. F. T., Hirsch‐Reinshagen, V., Tator, C. H., Wennberg, R. A., Kovács, G. G., & Tartaglia, M. C. (2024) · European Journal of Neurology · doi:10.1111/ene.16259 · Cited by 16
Yushkevich, P. A., Ittyerah, R., Li, Y., Denning, A. E., Sadeghpour, N., Lim, S., McGrew, E., Xie, L., de Florès, R., Brown, C. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14161 · Cited by 16
Quintas-Neves, M., Almeida, F., Gauthreaux, K. M., Teylan, M., Mock, C., Kukull, W. A., Crary, J. F., & Oliveira, T. G. (2024) · Neuroradiology · doi:10.1007/s00234-024-03464-2 · Cited by 16
Self-citationBrowne, D. F., Smirnov, D. S., Coughlin, D. G., Peng, I., Standke, H. G., Kim, Y., Pizzo, D. P., Unapanta, A., Andreasson, T., Hiniker, A. O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56469-7 · Cited by 16
Lewy-MSA hybrid fold drives distinct neuronal α-synuclein pathology
Enomoto, M., Martínez-Valbuena, I., Forrest, S. L., Xu, X., Munhoz, R. P., Li, J., Rogaeva, E. A., Lang, A. E., & Kovács, G. G. (2025) · Communications Biology · doi:10.1038/s42003-025-08355-7 · Cited by 16
Braak neurofibrillary tangle staging prediction from in vivo MRI metrics
Dallaire‐Théroux, C., Beheshti, I., Potvin, O., Dieumegarde, L., Saïkali, S., Duchesne, S., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.001 · Cited by 16
ELISA Evaluation of Tau Accumulation in the Brains of Patients with Alzheimer Disease
Shinohara, M., Hirokawa, J., Shimodaira, A., Tashiro, Y., Suzuki, K., Gheni, G., Fukumori, A., Matsubara, T., Morishima, M., Saito, Y., et al. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab047 · Cited by 16
Gogola, A., Lopresti, B. J., Tudorascu, D., Snitz, B. E., Minhas, D. S., Doré, V., Ikonomović, M. D., Shaaban, C. E., Matan, C., Bourgeat, P., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265941 · Cited by 16
Control tissue in brain banking: the importance of thorough neuropathological assessment
Nolan, M., Troakes, C., King, A., Bódi, I., & Al‐Sarraj, S. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1376-6 · Cited by 16
The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease
Robakis, D., Cortes, E. P., Clark, L. N., Vonsattel, J. P., Virmani, T., Alcalay, R. N., Crary, J. F., & Levy, O. A. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1552-3 · Cited by 16
Self-citationClustering of tau-immunoreactive pathology in chronic traumatic encephalopathy
Armstrong, R. A., McKee, A. C., Alvarez, V. E., & Cairns, N. J. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1635-1 · Cited by 16
Self-citationChronic Traumatic Encephalopathy
Iacono, D., Shively, S. B., Edlow, B. L., & Perl, D. P. (2017) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2016.12.007 · Cited by 16
Utility of spontaneous animal models of Alzheimer’s disease in preclinical efficacy studies
Zeiss, C. J. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03198-6 · Cited by 16
Tu, T., Jiang, J., Zhang, Q., Wan, L., Li, Y., Pan, A., Manavis, J., & Yan, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00093 · Cited by 16
Some New and Unexpected Tauopathies in Movement Disorders
Mulroy, E., Jaunmuktane, Z., Balint, B., Erro, R., Latorre, A., & Bhatia, K. P. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12995 · Cited by 16
Hayashi, H., Kobayashi, R., Kawakatsu, S., Morioka, D., & Otani, K. (2020) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000507654 · Cited by 16
Metadata
- Authors
- Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Gearing, M., Grinberg, L. T., Hof, P. R., Hyman, B. T., Jellinger, K., Jicha, G. A., Kovacs, G. G., Knopman, D. S., Kofler, J., Kukull, W. A., Mackenzie, I. R., Masliah, E., McKee, A., Montine, T. J., Murray, M. E., Neltner, J. H., Santa-Maria, I., Seeley, W. W., Serrano-Pozo, A., Shelanski, M. L., Stein, T., Takao, M., Thal, D. R., Toledo, J. B., Troncoso, J. C., Vonsattel, J. P., White, C. L., Wisniewski, T., Woltjer, R. L., Yamada, M., & Nelson, P. T.
- Affiliations
- Columbia University Irving Medical Center (US)
- University of Pennsylvania (US)
- Rush University Medical Center (US)
- University of Kentucky (US)
- Uppsala University (SE)
- Newcastle University (GB)
- Banner Sun Health Research Institute (US)
- Northwestern University (US)
- Washington University in St. Louis (US)
- Mayo Clinic (US)
- Emory University (US)
- Universidade de São Paulo (BR)
- Icahn School of Medicine at Mount Sinai (US)
- Harvard University (US)
- University of Pittsburgh Medical Center (US)
- University of Washington (US)
- University of British Columbia (CA)
- University of California San Diego (US)
- Boston University (US)
- University of California, San Francisco (US)
- Tokyo Metropolitan Geriatric Hospital (JP)
- Universität Ulm (DE)
- The University of Texas Southwestern Medical Center (US)
- Oregon Health & Science University (US)
- Kanazawa University (JP)
- Corresponding author
- Crary, John F.
- Nelson, Peter T.
- ORCID
- Crary, John F.
- Trojanowski, John Q.
- Schneider, Julie A.
- Abisambra, Jose F.
- Abner, Erin L.
- Alafuzoff, Irina
- Arnold, Steven E.
- Attems, Johannes
- Beach, Thomas G.
- Bigio, Eileen H.
- Dickson, Dennis W.
- Gearing, Marla
- Grinberg, Lea T.
- Hof, Patrick R.
- Hyman, Bradley T.
- Jellinger, Kurt
- Jicha, Gregory A.
- Knopman, David S.
- Kofler, Julia
- Kukull, Walter A.
- Mackenzie, Ian R.
- Masliah, Eliezer
- McKee, Ann
- Montine, Thomas J.
- Murray, Melissa E.
- Neltner, Janna H.
- Seeley, William W.
- Shelanski, Michael L.
- Stein, Thor
- Takao, Masaki
- Thal, Dietmar R.
- Troncoso, Juan C.
- White, Charles L.
- Woltjer, Randall L.
- Yamada, Masahito
- Nelson, Peter T.
- Venue
- Acta Neuropathologica
- Published
- 2014-10-28
- Volume
- 128
- Issue
- 6
- Pages
- 755-766
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4257842
- OpenAlex
- W1971032265
- Cited by
- 1,467
- References
- 160
- Citations by year
- 2026: 85 · 2025: 126 · 2024: 154 · 2023: 123 · 2022: 154 · 2021: 142 · 2020: 143 · 2019: 131 · 2018: 107 · 2017: 119 · 2016: 105 · 2015: 68 · 2014: 9
- FWCI
- 66.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Alzheimer's Association (P30 AG013854, P30AG010124, P01 AG003991, P50 AG025688, P50 AG005681, NIRG-11-204450, P50 AG005136, P50 AG005146)
- BrightFocus Foundation (U01 AG006786, P50 AG016574, P50 AG005136)
- Mayo Foundation for Medical Education and Research (AG016574)
- Alzheimer Forschung Initiative (#13803)
- Alzheimer's Society (AS-PG-2013-011)
- National Institute for Health and Care Research
- Bundesministerium für Bildung und Forschung
- National Institutes of Health (AG028 383, 5r01ag038651-10, AG016574, AG010124, AG005138, AG005133, AG005131, AG008051, AG005681, AG019610, AG003991, AG013854, AG025688, AG003949, AG005136, AG011378)
- Medical Research Council (G0400074, U01 AG006786)
- Japan Society for the Promotion of Science (26430060)
- National Institute on Aging (AG008051, R01‐AG038651, R01AG037212, P30AG028383, P01AG007232, P30AG012300, R37AG018440, P50AG005133, AG184440, U01AG016976, P50AG005131, P50AG005138, U01AG006786, P01AG003949, P30AG010124, AG005131, R01AG011378, P30AG008051, P50AG008702, P50AG005681, P30AG036453, P30AG019610, P50AG005146, P01AG003991, P30AG013846, P50AG005136, P30AG013854, P50AG025688, R01AG041851, P01AG002219, P01AG019724, P50AG016574)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- primary age-related tauopathy, neurofibrillary tangles, tau pathology, Alzheimer's disease, nomenclature, temporal lobe atrophy, tau biomarkers, tau imaging, brain aging, cognitive impairment
- MeSH terms
- Aging, Brain, Diagnosis, Differential, Humans, Terminology as Topic, Tauopathies, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
